June 4, 2015—The trend in cancer care away from physician offices toward hospital settings has little to do with the 340B program, and restricting 340B to alleviate the shift would only hurt vulnerable patients, two nationally prominent oncologists write in the Journal of Oncology Practice.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)